Trauma

Disease

Related News

Psychedelic Therapies Show Promise for Depression, Anxiety and Addiction

Clinical trials show psychedelic substances like psilocybin, LSD and MDMA combined with therapy can effectively treat depression, anxiety and addiction. Several substances are in Phase III trials, with esketamine already approved for treatment-resistant depression. Research suggests these treatments may work with fewer doses than traditional medications.

Related Clinical Trials

NCT ID Title Status Phase
NCT07589777

Trauma-Informed Yoga Intervention in Young Women

NOT_YET_RECRUITING NA
NCT07585916

Prenatal Yoga Intervention in Pregnant Women

RECRUITING NA
NCT07581327

Data-Driven Lay First Responder Program in Cameroon

NOT_YET_RECRUITING NA
NCT07536854

Early Delirium Prediction Via Serial EEG Trajectories and Machine Learning

COMPLETED
NCT07492758

Management of Extremity Injuries Registry

COMPLETED
NCT07490197

Acute Subdural Hematoma

RECRUITING
NCT07490171

Traumatic Cardiac Arrest

RECRUITING
NCT07490158

Enteric Anastomoses

RECRUITING
NCT07490145

Trauma Activation Criteria

RECRUITING
NCT07485231

Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD

RECRUITING NA